Skip to main content

Abstract

The incidence of suicide in adolescents has been increasing, making it more and more important to arrive at an accurate diagnosis and to mount effective prevention programs.1 Efforts to construct a behavior profile that predicts risk of attempted or completed suicide have been unsuccessful. Only weak correlations exist at present between suicide and types of premorbid behavior. Current profiles of the child at suicide risk turn up many false-positive results,2 suggesting that available models have low specificity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Curran DK: Adolescent Suicidal Behavior. Hagerstown, Maryland, Harper & Row, 1987, pp 14

    Google Scholar 

  2. Cohen J: Statistical approaches to suicidal risk factor analysis, in Stanley M Mann JJ (eds), Psychobiology of Suicidal behavior. New York, New York Academy of Sciences, 1986, pp 34–41

    Google Scholar 

  3. Lloyd KG, Farley IJ, Deck JHN, et al : Serotonin and 5-hydroxyindoleacetic acid in discrete areas of the brainstem of suicide victims and control patients, in Advances in Biochemical Psychopharmacology, Vol. II. New York, Raven Press, 1974, pp 387–397

    Google Scholar 

  4. Pare CMB, Yeung DPH, Price K, et al : 5-Hydroxytryptamine, noradrenaline and dopamine in brain steam, hypothalamus and caudate nucleus of controls of patients committing suicide by coal-gas poising. Lancet 1:131–135, 1969

    Google Scholar 

  5. Shaw DM, Camps FE, Eccleston EG : 5-hydroxytryptamine in the hind brain of depressive suicides. Br J Psychiatry 113:1407–1411, 1967

    Article  PubMed  CAS  Google Scholar 

  6. Korpi ER, Kleinman JE, Goodman SI, et al : Serotonin and 5-hydroxyindolacetic acid concentrations in different brain regions of suicide victims: Comparison in chronic schizophrenic patients with suicide as cause of death. Presented at theInternational Society of Neurochemistry, Vancouver, Canada 1983

    Google Scholar 

  7. Gillin JC, Kelsoe JR, Kaufman CA, et al : Muscarinic receptor density in skin fibroblasts and autopsied brain tissue in affective disorder. Presented atPsychobiology of Suicide Behavior. New York, New York Academy of Sciences, September 1985, pp 143–147

    Google Scholar 

  8. Bourne HR, Bunney WE Jr, Colburn RW, et al: Noradrenaline, 5-hydroxytryptamine, and 5-indoleacetic acid in the human brain: Post mortem studies in a group of suicides and in a control group. Lancet 2:805–808, 1968

    Article  PubMed  CAS  Google Scholar 

  9. Beskow J, Gottfriess GC, Roos BE, et al : Determination of monoamine and monoamine metabolites in the human brain: post mortem studies in a group of suicides and in a control group. Acta Psychiatr Scand 53:7–20, 1976

    Article  PubMed  CAS  Google Scholar 

  10. Stanley M, Mann JJ : Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet 2:214–216, 1983

    Article  Google Scholar 

  11. Crow TJ, Cross AJ, Cooper SJ, et al : Neurotransmitter receptors and monoamine metabolites in the patient with Alzheimer-type dementia and depression and suicides. Neuropharmacology 23:1561–1569, 1984

    Article  PubMed  CAS  Google Scholar 

  12. Owen F, Cross AJ, Crow TJ, et al : Brain 5-HT2 receptors and suicide. Lancet 2:1256, 1963

    Google Scholar 

  13. Grote SS, Moses SG, Robins, E, et al : A study of selected catecholamine metabolizing enzymes: A comparison of depressive suicides and alcoholic suicides with controls. J Neurochem 23:791–236, 1974

    Article  PubMed  CAS  Google Scholar 

  14. Gottfries, CG, Knorring LV, Oreland L : Platelet monamine oxidase activity in brains from alcoholic. J Neurochem, 25:667–673, 1975

    Article  PubMed  CAS  Google Scholar 

  15. Mann JJ, Stanley M : Postmortem monoamine oxidase enzyme kinetics in the frontal cortex of suicide victims and controls. Acta Psychiatr Scand 69:135–139, 1984

    Article  PubMed  CAS  Google Scholar 

  16. Langer SZ, Moret C, Raisman R, et al ; High-affinity [3H]imipramine binding in rat hypothalamus: Association with uptake of serotonin but not of norepinephrine. Science 210:1133–1135, 1980

    Article  PubMed  CAS  Google Scholar 

  17. Brunello N, Chuang DM, Costa E : Different synaptic location of mianserin and imipramine binding sites. Science 215:1112–1115, 1982

    Article  PubMed  CAS  Google Scholar 

  18. Rehavi M, Skolnick P, Paul SM : Solubilization and partial purification of the high affinity [3H]imipramine binding site from human platelets. FEBS Lett 150:514–518, 1982

    Article  PubMed  CAS  Google Scholar 

  19. Raisman R, Sechter D, Briley MS, et al : High affinity 3H-imipramine binding in platelets from untreated and treated depressed patients compared to healthy volunteers. Psychopharmacology 75:368–371, 1981

    Article  PubMed  CAS  Google Scholar 

  20. Stanley M, Virgilio J, Gershon S : Tritiated imipramine binding sites are decreased in the frontal cortex of suicides. Science 216:1337–1339, 1982

    Article  PubMed  CAS  Google Scholar 

  21. Paul SM, Rehavi M, Skolnick P, et al : High affinity binding of antidepressants to a biogenic amine transport site in human brain and platelet: Studies in depression, in Post RM Ballenger JC(eds), Neurobiology and Mood Disorders. Baltimore, William & Wilkins, 1984, pp 846–853

    Google Scholar 

  22. Meyerson LR, Wennogle LP, Abel MS, et al : Human brain receptor alterations in suicide victims. Pharmacol Biochem Behav 17:159–163, 1982

    Article  PubMed  CAS  Google Scholar 

  23. Peroutka SJ, Snyder SH : Regulation of serotonin (5-HT2) labeled with [3H] spiroperidol by chronic treatment with antidepressant amitriptyline. Pharmacol Exp Therap 215:582–587, 1980

    CAS  Google Scholar 

  24. Mann JJ, Stanley M, McBride AP, et al : Increased serotonin and beta-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry 43:954–959, 1986

    Article  PubMed  CAS  Google Scholar 

  25. Meltzer HY, Nash JF, Ohmori T, et al : Neuroendocrine and biochemical studies of serotonin and dopamine in depression and suicide. International Conference on New Directions in Affective Disorders, S60, 1987

    Google Scholar 

  26. Cheetham SC, Crompton MR, Katona CLE, Horton RW : Brain 5-HT2 receptor binding sites in depressed suicide victims. Brain Res. 443:272–280, 1988

    Article  PubMed  CAS  Google Scholar 

  27. Janowsky DS, El-Yousef MK, David JM, et al : A cholinergic-adrenergic hypothesis of mania and depression. Lancet 1:632, 1972

    Article  Google Scholar 

  28. Stanley M : Cholinergic receptor binding in the frontal cortex of suicide victims. Am J Psychiatry 141:1432–1436, 1984

    PubMed  CAS  Google Scholar 

  29. Kaufman CA, Gillin JC, Hill B, et al : Muscarinic binding sites in suicides. Psychiatry Res 12:47–55, 1984

    Article  Google Scholar 

  30. Sulser F, Robonson SE : Clinical implications of pharmacological differences among antipsychotic drugs, In Lipton MA DiMascio A Killam KF(eds), Psychopharmacology: A Generation of Progress. New York, Raven, 1978, pp 943–954

    Google Scholar 

  31. Zanko MT, Biegon A : Increased p-adrenergic receptor binding in human frontal cortex of suicide victims. Abstract of theAnnual Meeting, Society of Neuroscience, Boston, 1983

    Google Scholar 

  32. Biegon A : Findings in beta receptors in suicide victims. Grand Rounds, Rockefeller University, June 1987

    Google Scholar 

  33. Nemeroflf CB, Widerlow E, Bissett G, et al: Arch Gen Psychiatry, 45:577–579, 1988

    Article  Google Scholar 

  34. Ashby P, Verrier M, Wash JJ, et al : Spinal reflexes and the concentrations of 5-HIAA, MHPG and HVA in lumbar cerebrospinal fluid after spinal lesions in man. J Neurol Neurosurg Psychiatry 39:1191–1200, 1976

    Article  PubMed  CAS  Google Scholar 

  35. Curzon G, Gumpert EJ, Sharpe DM : Amine metabolites in the lumbar cerebrospinal fluid of humans with restricted flow of cerebrospinal fluid. Nature New Biol 231:189–191, 1971

    PubMed  CAS  Google Scholar 

  36. Post RM, Goodwin FK, Gordon E, et al : Amine metabolites in human cerebrospinal fluid: Effects of cord transection and spinal fluid block. Science 179:897–899, 1973

    Article  PubMed  CAS  Google Scholar 

  37. Stanley M, Traskman-Bendz L, Dorovini-Zis K : Correlations between aminergic metabolites simultaneously obtained from human CSF and brain. Life Sci 37:1279–1286, 1985

    Article  PubMed  CAS  Google Scholar 

  38. Asberg M, Thoren P, Traskman L, et al: Serotonin depression: A biochemical subgroup within the affective disorders? Science 191:478–480, 1976

    Article  PubMed  CAS  Google Scholar 

  39. Asberg M, Traskman L, Birtilson L, et al : Studies of CSF 5-HIAA in depression and suicidal behavior. Exp Med Biol 133:739–752, 1981

    CAS  Google Scholar 

  40. Agren H : Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolites in the cerebrospinal fluid. II. Suicide Psychiatry Res 3:225–236, 1980

    CAS  Google Scholar 

  41. Van Praag HM : Depression, suicide and the metabolism of serotonin in the brain. J Affective Dis 4:275–290, 1982

    Article  Google Scholar 

  42. Banki CM, Arato M, Papp Z, et al : Biochemical markers in suicidal patients: Investigations with cerebrospinal fluid amine metabolites and neuroendocrine tests. J Affective Dis 6:341–350, 1984

    Article  CAS  Google Scholar 

  43. Palanappian V, Ramachandran V, Somasundaram O : Suicidal ideation and biogenic amines in depression. Indian J Psychiatry 25:268–292, 1983

    Google Scholar 

  44. Montgomery SA, Montgomery D : Pharmacological prevention of suicidal behavior. J Affective Dis 4:291–298, 1982

    Article  CAS  Google Scholar 

  45. Perez de los Cobos JZ, Lopez-Ibor Alino JJ, Saiz Ruiz J : Correlatos biologicaos del suicido y la agresivivad en depressiones mayores (con melancholia): 5-HIAA en LCR, DST, y respuesta terapeutica a 5-HTP. Presented at the First Congress of the Spanish Society for Biological Psychiatry, Barcelona, 1984

    Google Scholar 

  46. Brown GL, Goodwin FK, Ballenger JC, et al : Aggression in humans correlates with cerebrospinal fluid amine metabolism. Psychiatry Res 1:131–139, 1979

    Article  PubMed  CAS  Google Scholar 

  47. Brown GL, Ebert MH, Goyer PF, et al : Aggression, suicide and serotonin; relationships to CSF amine metabolites. Am J Psychiatry 139:741–746, 1982

    PubMed  CAS  Google Scholar 

  48. Traskman L, Asberg M, Bertillsson K, et al : Monoamine metabolites in CSF and suicidal behavior. Arch Gen Psychiatry 38:631–636, 1981

    Article  PubMed  CAS  Google Scholar 

  49. Linnoila M, Virkkunen M, Scheinin M, et al : Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentrations differentiates impulsive violent behavior. Life Sci 33:2609–2614, 1983

    Article  PubMed  CAS  Google Scholar 

  50. Van Praag HM : CSF 5-HIAA and suicide in non-depressed schizophrenics. Lancet 2:977–978, 1984

    Google Scholar 

  51. Ninan PT, Van Kammen DP, Scheinin M, et al : CSF 5-hydroxyindoleacetic acid in suicidal schizophrenic patients. Am J Psychiatry 141:566–569, 1984

    PubMed  CAS  Google Scholar 

  52. Miles CL : Conditions predisposing to suicide. J Nerv Ment Dis 164:231–246, 1977

    Article  PubMed  CAS  Google Scholar 

  53. Tsuang MT : Suicide in schizophrenics, manics, depressives, and surgical controls. Arch Gen Psychiatry 35:153–155, 1978

    Article  PubMed  CAS  Google Scholar 

  54. Roy A : Suicide in chronic schizophrenics. Br J Psychiatry 144:171–177, 1982

    Article  Google Scholar 

  55. Roy A, Ninam P, Mazonson A, et al : CSF monoamine metabolite in chronic schizophrenia patients who attempt suicide. Psychol Med 15:335–340, 1985

    Article  PubMed  CAS  Google Scholar 

  56. Pickar D, Roy A, Brier A, et al : Suicide and aggression in schizophrenia: neurobiologic correlates, in Mann JJ Stanley M(eds), Psychobiology of Suicidal Behavior. New York, New York Academy of Sciences, 1986, pp 189–196

    Google Scholar 

  57. Jamison KR : Suicide and bipolar disorders, in Mann JJ Stanley M(eds), Psychobiology of Suicidal Behavior. New York, New York Academy of Sciences, 1986, pp 301–315

    Google Scholar 

  58. Roy-Byme P, Post RM, Rubinow DR, et al : CSF 5-HIAA and personal and family history of suicide in affectively ill patients: a negative study. Psychiatry Res 10:263–274, 1983

    Article  Google Scholar 

  59. Berrettini W, Nurenberger J, Narrow W, et al : Cerebrospinal fluid studies of bipolar patients with and without a history of suicide attempts, in Mann JJ Stanley M(eds): Psychobiology of Suicidal Behavior. New York, New York Academy of Sciences, 1986, pp 197–201

    Google Scholar 

  60. Goodwin FK : Suicide aggression and depression: A theoretical framework for future research, in Mann JJ Stanley M(eds), Psychobiology of Suicidal Behavior. New York, New York Academy of Sciences, 1986, pp 351–356

    Google Scholar 

  61. Banki C, Arato M, Kilts C : Aminergic studies and cerebrospinal fluid cautions in suicide, in Mann JJ Stanley M(eds), Psychobiology of Suicidal Behavior. New York, New York Academy of Sciences, 1986, pp 221–230

    Google Scholar 

  62. Banki C : Factors influencing monoamine metabolites and tryptophan in patients with alcohol dependence. J Neural Transm 50:98–101, 1981

    Article  Google Scholar 

  63. Ballenger JC, Goodwin FK, Major LF, et al : Alcohol and central serotonin metabolism in man. Arch Gen Psychiatry 36:224–227, 1979

    Article  PubMed  CAS  Google Scholar 

  64. Tabakoff B, Ritzmann R : Inhibition of the transport of 5-hydroxyindoleacetic acid from brain by ethanol. J Neurochem 24:1043–1051, 1975

    Article  PubMed  CAS  Google Scholar 

  65. Ellingboe J : Effect of alcohol on neurochemical processes, in Lipton M DiMascio A Killman K(eds), Psychopharmacology: A Generation of Progress. New York, Raven, 1978, pp 1653–1654

    Google Scholar 

  66. Herrero E : Monoamine metabolism in rat brain regions following long-term alcohol treatment. J Neural Transm 47:227–236, 1980

    Article  Google Scholar 

  67. Secunda JA, Cross CK, Koslow K, et al : Biochemistry and suicidal behavior in depressed patients. Biol Psychiatry 21:756–767, 1986

    Article  PubMed  CAS  Google Scholar 

  68. Oreland L, Wilberg A, Asberg M, et al : Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls. Psychiatry Res 4:21–29, 1981

    Article  PubMed  CAS  Google Scholar 

  69. Arato M, Banki CM, Nemeroff CB, et al : Hypothalamic-pituitary-adrenal axis and suicide, in Mann JJ Stanley M, (eds), Psychobiology of Suicidal Behavior. New York, New York Academy of Sciences, 1986, pp 263–270

    Google Scholar 

  70. Stoff D, Pollack L, Bridger WL : Platelet imipramine binding sites correlate with aggression in adolescents. Biol Psychiatry 12:180–182, 1986

    Google Scholar 

  71. Shaffer D, Bacon K : A critical review of prevention intervention efforts in suicide with particular preference to youth suicide. Prepared for thePrevention and Intervention Work Group of HHS Task Force on Youth Suicide. Presented inOakland, California, June 11–13, 1986

    Google Scholar 

  72. Grottfries CG, Knorring LV, Oreland L : Platelet monamine oxidase activity in mental disorders. Neuropsychopharmacology 4:185–192, 1980

    Article  Google Scholar 

  73. Buchsbaum MS, Hairr RJ, Murphy DL : Suicide attempts, platelet monoamine oxidase and the average evoked response. Acta Psychiatry Scand 56:69–77, 1979

    Article  Google Scholar 

  74. Meltzer HY, Arora RC : Platelet markers of suicidality, in Mann JJ Stanley M(eds), Psychobiology of Suicidal Behavior. New York, New York Academy of Sciences, 1986, pp 271–280

    Google Scholar 

  75. Bunney WE Jr, Fawcett JA, Davis JM, et al: Possibility of a biochemical test for suicidal potential. Arch Gen Psychiatry 13:232–239, 1965

    Article  PubMed  CAS  Google Scholar 

  76. Bunney WE Jr, Fawcett JA, Davis JM, et al: Further evaluation of urinary 17-hydroxycorticosteroids in suicidal patients. Arch Gen Psychiatry 21:138–150, 1969

    Article  PubMed  Google Scholar 

  77. Ostroff R, Giller E, Bonese K, et al : Neuroendocrine risk factors of suicide. Am J Psychiatry 139:1323–1325, 1982

    PubMed  CAS  Google Scholar 

  78. Levy B, Hensen E : Failure of the urinary test for suicidal potential. Arch Gen Psychiatry 20:415–418, 1969

    Article  PubMed  CAS  Google Scholar 

  79. Carroll BJ, Greden JF, Feinberg M : Suicide, neuroendocrine dysfunction and CSF 5-HIAA concentrations in depression, in Angrist B (ed), Recent Advances in Neuropsychopharmacology. Oxford, Pergamon, 1981, pp 307–313

    Google Scholar 

  80. Kocsis JH, Kennedy S, Brown RP, et al : Neuroendocrine studies in depression: Relationship to suicidal behavior, in Mann JJ Stanley M(eds), Psychobiology of Suicidal Behavior. New York, New York Academy of Sciences, 1986, pp 256–262

    Google Scholar 

  81. Targum SD, Rosen L, Capodanno AE : The dexamethasone suppression test in suicidal patients with unipolar depression. Am J Psychiatry 140:877–879, 1983

    PubMed  CAS  Google Scholar 

  82. Banki CM, Aroto M : Amine metabolites and neuroendocrine responses related to depression and suicide. J Affective Disord 5:223–232, 1983

    Article  CAS  Google Scholar 

  83. Van Waltere JP, Charles G, Wilmotte J : Tests de function a la dexamethasome et suicide. Acta Psychiatr Scand 83:569–578, 1983

    Google Scholar 

  84. Meltzer HY, Perline R, Tricou BJ, et al : Affect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. II. Relation to suicide, psychosis and depressive symptoms. Arch Gen Psychiatry 41:379–387, 1984

    Article  PubMed  CAS  Google Scholar 

  85. Cocarro EF, Siever LJ, Klar H, et al : Serotonergic studies in patients with affective and personality disorders. Arch Gen Psychiatry 46:587–599, 1989

    Article  Google Scholar 

  86. Stanley MM, Mann JJ : Biological factors associated with suicide, in Frances AJ and Hales RE, APA Review of Psychiatry, Vol. 7, 1987, pp 334–352

    Google Scholar 

  87. Valzelli L : Psychobiology of Aggression and Violence. New York, Raven, 1981

    Google Scholar 

  88. Cochran E, Robins E, Grote S : Regional serotonin levels in brain: A comparison of depressive suicides and alcoholic suicides with controls. Biol Psychiatry 11:283–295, 1976

    PubMed  CAS  Google Scholar 

  89. Beskow J, Gottfries CG, Roos BE, et al : Determination of monoamine and monoamine metabolites in the human brain: Postmortem studies in a group of suicides and in a control group. Acta Psychiatr Scand 53:7–20, 1976

    Article  PubMed  CAS  Google Scholar 

  90. Bourse HR, Bunney WE Jr, Colburn RW, et al: Noradrenadine, 5-hydroxyindoleacetic acid of suicidal patients. Lancet ii:805–808, 1968

    Google Scholar 

  91. Korpi ER, Kleinman JE, Goodman SI, et al : Serotonin and 5-hydroxyindoleacetic acid concentrations in different brain regions of suicide victims: Comparison in chronic Schizophrenic patients with suicide as cause of death. Presented at theInternational Society for Neurochemistry, Vancouver, Canada, 1983

    Google Scholar 

  92. Crow TJ, Cross AJ, Cooper SJ, et al : Neurotransmitter receptors and monoamine metabolites in the patients with alzheimer-type dementia and depression and suicides. Neuropharmacology 23:1561–1569, 1984

    Article  PubMed  CAS  Google Scholar 

  93. Perry EK, Marshall EF, Blessed G, et al : Decreased imipramine binding in the brains of patients with depresseve illness. Br J Psychiatry 142:188–192, 1983

    Article  PubMed  CAS  Google Scholar 

  94. Owens F, Cross AJ, Crow TJ, et al : Brain 5-HT receptors and suicide. Lancet 2:1283, 1983

    Google Scholar 

  95. Zanko MT, Biegon A : Increased B-adrenergic receptor binding in human frontal cortex of suicide victims. Abstr. of theAnnual Meeting, Society of Neuroscience, Boston, 1983

    Google Scholar 

  96. Mann JJ, Stanley M, McBride AP, et al : Increased serotonin and beta-adrenergic receptor binding in the frontal orifices of suicide victims. Arch Gen Psychiatry 43:954–959, 1986

    Article  PubMed  CAS  Google Scholar 

  97. Traskman L, Asberg M, Bertilsson K, et al : Monoamine metabolites in CSF and suicidal behavior. Arch Gen Psychiatry 38:631–636, 1987

    Article  Google Scholar 

  98. Montgomery SA, Montgomery D : Pharmacological prevention of suicidal behavior. J Affective Disord 4:291–298, 1982

    Article  CAS  Google Scholar 

  99. Palanappian V, Rauachandler V, Somosundaran O : Suicidal ideation and biogenic amines in depression. Indian J Psychiatry 25:268–292, 1983

    Google Scholar 

  100. Banki CM, Arato M, Papp Z, et al : Biochemical markers in suicidal patients: Investigations with cerebrospinal fluid amine metabolites and neuroendocrine tests. J Affective Disord 6:341–350, 1984

    Article  CAS  Google Scholar 

  101. Perez de los Cobos JZ, Lopez-Ibor Alino JJ, Saiz Ruiz J : Correlatos biologicos del suicido y la agresividad en depressiones mayores (con melancolia): 5-HIAA en LCR, DST, y respuesto terapeutica a 5-HTp. Presented to the first Congress of the Spanish Society for Biological Psychiatry, Barcelona, 1984

    Google Scholar 

  102. Berrettini W, Nurenberger J, Narrow W, et al. : Cerebrospinal fluid studies of bipolar patients with and without a history of suicide attempts, in Mann JJ Stanley M(eds), Psychobiology of Suicidal Behavior, New York, New York Academy of Sciences, 1986

    Google Scholar 

  103. Van Praag HM : CSF 5-HIAA and suicide in nondepressed schizophrenics. Lancet 2:977–978, 1983

    Article  PubMed  Google Scholar 

  104. Ninan PT, Van Kammen DP, Scheinin M, et al : CSF 5-hydroxyindoleacetic acid in suicidal schizophrenic patients. Am J Psychiatry 141:566–569, 1984

    PubMed  CAS  Google Scholar 

  105. Stanley M, Stanley B, Traskman-Bendz L, Winchel R, and Jones JS : An assessment of the biochemical findings in schizophrenic patients who attempt suicide. Athens, Greece, VIII World Congress of Psychiatry, Abstract, 1989

    Google Scholar 

  106. Banki CM, Alato M : Amine metabolites and neuroendocrine responses related to depression and suicide. J. Affective Disord 5:225–232, 1983

    Article  Google Scholar 

  107. Brown GL, Goodwin FK, Ballenger, JC, et al : Ag ression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res. 1:131–139, 1979

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Plenum Publishing Corporation

About this chapter

Cite this chapter

Birmaher, B., Greenhill, L.L., Stanley, M. (1990). Biochemical Studies of Suicide. In: Deutsch, S.I., Weizman, A., Weizman, R. (eds) Application of Basic Neuroscience to Child Psychiatry. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0525-5_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-0525-5_20

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-7849-8

  • Online ISBN: 978-1-4613-0525-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics